We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
- Authors
Khoury, Samia J; Healy, Brian C; Kivisäkk, Pia; Viglietta, Vissia; Egorova, Svetlana; Guttmann, Charles R G; Wedgwood, Josiah F; Hafler, David A; Weiner, Howard L; Buckle, Guy; Cook, Sandra; Reddy, Susheel
- Abstract
Interleukin 12 (IL-12), a cytokine that promotes generation of helper T cells subtype 1, is increased in multiple sclerosis. Albuterol sulfate, a β2-adrenergic agonist, reduces IL-12 expression, so we tested the effect of albuterol as an add-on treatment to glatiramer acetate therapy.
- Publication
Archives of neurology, 2010, Vol 67, Issue 9, p1055
- ISSN
1538-3687
- Publication type
Journal Article
- DOI
10.1001/archneurol.2010.222